Enhanced Tumor Modeling Using Laponite Bioinks for 3D Bioprinting (IMAGE)

Terasaki Institute for Biomedical Innovation

Enhanced Tumor Modeling Using Laponite Bioinks for 3D Bioprinting

Caption

Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have formulated a tuneable, nanoengineered bioink for tumor modeling which contains highly charged, disc shaped Laponite nanoparticles. These nanoparticles were shown to retain the biological signaling that occurs in the tumor microenvironment so that more accurate tumor models can be created for study and anti-tumor drug development.

Credit

Terasaki Institute for Biomedical Innovation

Usage Restrictions

Request permission from Terasaki Institute for Biomedical Innovation

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.